Herrmann, Ken <br/><br/>
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL.  [electronic resource] 

 -  Oncotarget  Jun 2014 
 - 4050-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.1990  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Female<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Positron-Emission Tomography--methods<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Rituximab<br/>Vincristine--therapeutic use